Legend Biotech Corporation announced that at the annual general meeting of shareholders held on October 14, 2022, elected Mr. Philip Yau as a Class II director for a three year term.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.56 USD | +6.69% | +7.45% | -22.62% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.62% | 8.49B | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.23% | 22.82B | |
-10.39% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech Corporation Elects Philip Yau as Director